Counterforce Health (Page 69)

More issues

How to Get Pyrukynd (mitapivat) Covered by Aetna (CVS Health) in Georgia: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Pyrukynd (mitapivat) Covered by Aetna (CVS Health) in Georgia Aetna (CVS Health) requires prior authorization for Pyrukynd (mitapivat) as a non-formulary medication for adults with pyruvate kinase deficiency. Approval requires genetic confirmation (≥2 PKLR variants with ≥1 missense), hemoglobin ≤10 g/dL or transfusion history, and hematologist

Work With Your Doctor to Get Vimizim (Elosulfase Alfa) Approved by UnitedHealthcare in Pennsylvania: Medical Necessity Letters, Appeals, and Provider Collaboration

Answer Box: Getting Vimizim Approved in Pennsylvania UnitedHealthcare requires prior authorization for Vimizim (elosulfase alfa) through OptumRx, with strict diagnostic and functional requirements for MPS IVA patients. Your fastest path: (1) Schedule with a pediatric geneticist or metabolic specialist at Children's Hospital of Philadelphia or Nemours, (2) Gather

How to Get Opfolda (miglustat) Covered by Cigna in Texas: Complete PA Guide & Appeals Process

Answer Box: Getting Opfolda (miglustat) Covered by Cigna in Texas Cigna requires prior authorization for Opfolda (miglustat) in Texas adults with late-onset Pompe disease (LOPD) weighing ≥40 kg who aren't improving on current enzyme replacement therapy. The drug must be prescribed with Pombiliti as combination therapy. Submit PA

How to Get Givlaari (Givosiran) Covered by Florida Blue Cross Blue Shield: Complete Forms, Appeals, and Approval Guide

Quick Answer: Getting Givlaari Covered by Florida Blue in 2024 Florida Blue requires prior authorization for Givlaari (givosiran) with specific medical criteria. Submit your request through Availity.com or call 1-877-719-2583. You'll need confirmed acute hepatic porphyria diagnosis with elevated PBG/ALA levels, genetic testing, and documented attack

How to Get Tagrisso (Osimertinib) Covered by Cigna in Pennsylvania: Complete Guide to Prior Authorization and Appeals

Answer Box: Getting Tagrisso Covered by Cigna in Pennsylvania Cigna covers Tagrisso (osimertinib) with prior authorization for EGFR mutation-positive NSCLC. Your fastest path to approval: 1. Confirm EGFR mutation status via FDA-approved testing (exon 19 deletion, L858R, or T790M) 2. Submit PA through Cigna provider portal using form CNF-550 with

How Long Does It Take to Get Prolastin-C Approved by UnitedHealthcare in Virginia? Complete Timeline Guide

Quick Answer: Getting Prolastin-C approved by UnitedHealthcare in Virginia typically takes 5-7 business days for standard prior authorization or 72 hours for urgent requests. You'll need severe AAT deficiency documentation (Pi*ZZ genotype), emphysema proof via chest CT, and pulmonary function tests. If denied, Virginia gives you 120

If Jakafi Isn't Approved by Aetna (CVS Health) in North Carolina: Formulary Alternatives & Exception Paths

Quick Answer: Your Options When Aetna Denies Jakafi If Aetna (CVS Health) denies Jakafi (ruxolitinib) in North Carolina, you have three main paths: try formulary alternatives like IBTROZI (ropeginterferon alfa-2b), request a formulary exception with medical necessity documentation, or appeal the denial through Aetna's internal process followed by

How to Get Increlex (mecasermin) Covered by Cigna in Illinois: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Increlex (mecasermin) Covered by Cigna in Illinois Cigna requires prior authorization for Increlex (mecasermin) through a pediatric endocrinologist, typically placing it on Tier 4/5 specialty formularies. Your first step: verify your plan type (HMO requires PCP referral; PPO doesn't) and gather IGF-1 labs, growth

Myths vs. Facts: Getting Xywav (Ca/Mg/K/Na oxybates) Covered by Humana in California

Answer Box: Getting Xywav Covered by Humana in California Xywav requires prior authorization from Humana due to its high cost and REMS requirements. The fastest path: ensure your prescriber is REMS-certified, submit complete medical necessity documentation including diagnosis codes and prior treatment failures, and use Humana's provider portal

How to Get Xenpozyme (olipudase alfa-rpcp) Covered by Blue Cross Blue Shield in Pennsylvania: Complete Coding, Appeals, and Authorization Guide

Answer Box: Getting Xenpozyme Covered in Pennsylvania Xenpozyme (olipudase alfa-rpcp) requires prior authorization from Blue Cross Blue Shield plans in Pennsylvania. Use ICD-10 codes E75.240 (type A), E75.241 (type B), or E75.244 (type A/B) for ASMD diagnosis. Submit PA with genetic confirmation, baseline organ assessments, and